(1.00%) 5 114.80 points
(1.10%) 38 647 points
(1.75%) 16 119 points
(-0.32%) $78.70
(0.34%) $2.04
(-0.37%) $2 301.10
(-0.83%) $26.61
(0.30%) $965.50
(-0.36%) $0.929
(-1.23%) $10.86
(-0.13%) $0.797
(0.21%) $91.32
0.77% $ 0.935
Live Chart Being Loaded With Signals
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders...
Stats | |
---|---|
Dzisiejszy wolumen | 401 467 |
Średni wolumen | 29 535.00 |
Kapitalizacja rynkowa | 3.02M |
EPS | $0 ( 2024-03-14 ) |
Następna data zysków | ( $-0.230 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0300 |
ATR14 | $0.122 (0.74%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Alloway Paul | Buy | 23 530 | Common Stock |
2024-03-25 | Alloway Paul | Sell | 18 090 | Restricted Stock Units |
2024-03-25 | Michaud Charles Jr | Buy | 6 448 | Common Stock |
2024-03-25 | Michaud Charles Jr | Sell | 5 360 | Restricted Stock Units |
2024-01-01 | Tzianabos Arthur | Buy | 19 140 | Common Stock |
INSIDER POWER |
---|
35.77 |
Last 94 transactions |
Buy: 1 681 707 | Sell: 632 243 |
Homology Medicines Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RMRM | 0.923 |
TBNK | 0.904 |
FNWB | 0.903 |
GRPN | 0.9 |
TFSL | 0.895 |
VTRS | 0.895 |
HMST | 0.891 |
APDN | 0.889 |
TCPC | 0.886 |
VERU | 0.886 |
10 Najbardziej negatywne korelacje | |
---|---|
ZGNX | -0.915 |
ADMS | -0.913 |
UNCY | -0.886 |
RESN | -0.877 |
TYHT | -0.876 |
ORTX | -0.874 |
BLCT | -0.87 |
PLPC | -0.869 |
CNST | -0.864 |
CNCE | -0.861 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Homology Medicines Inc Korelacja - Waluta/Towar
Homology Medicines Inc Finanse
Annual | 2023 |
Przychody: | $1.16M |
Zysk brutto: | $578 000 (50.00 %) |
EPS: | $-1.950 |
FY | 2023 |
Przychody: | $1.16M |
Zysk brutto: | $578 000 (50.00 %) |
EPS: | $-1.950 |
FY | 2022 |
Przychody: | $3.21M |
Zysk brutto: | $609 000 (18.98 %) |
EPS: | $0.00840 |
FY | 2021 |
Przychody: | $33.97M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.901 |
Financial Reports:
No articles found.
Homology Medicines Inc
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej